Below is quote on Vijaya Diagnostic IPO listing by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd
Vijay Diagnostic Centre Limited ipo debut at premium of 8% to its upper band of the IPO price. Company is trading at price to earning of 67 times and EV/EBITDA OF 32 times based on FY2021 numbers which is on higher side as compared to its peers. Looking at higher valuations and limited growth potential in its key geographic we have a neutral outlook on Vijaya Diagnostics centre.
Above views are of the author and not of the website kindly read disclaimer